9-ethyladenine

Networked: 4 relevant articles (0 outcomes, 1 trials/studies)

1.	Cristalli, Gloria: 2 articles (06/2009 - 04/2005)
2.	Volpini, Rosaria: 2 articles (06/2009 - 04/2005)
3.	Dal Ben, Diego: 1 article (06/2009)
4.	Klotz, Karl-Norbert: 1 article (06/2009)
5.	Lambertucci, Catia: 1 article (06/2009)
6.	Martini, Claudia: 1 article (06/2009)
7.	Marucci, Gabriella: 1 article (06/2009)
8.	Mishra, Ram Chandra: 1 article (06/2009)
9.	Ramadori, Anna Teresa: 1 article (06/2009)
10.	Trincavelli, Maria Letizia: 1 article (06/2009)

1.	Parkinson Disease (Parkinson's Disease) 04/11/2005 - "Taken together the results of this study indicate that some 8-substituted 9-ethyladenine derivatives ameliorate motor deficits in rat models of Parkinson's disease, suggesting a potential therapeutic role of these compounds." 06/01/2009 - "Recently, three 9-ethyladenine derivatives bearing a bromine atom, an ethoxy group, and a furyl ring, respectively, in the 8-position have been reported to ameliorate motor deficits in rat Parkinson's disease models, suggesting a potential therapeutic role for these compounds. "
2.	Colorectal Neoplasms (Colorectal Cancer) 01/01/1997 - "Bases such as 9-ethyladenine, N6-2-isopentenyladenine and N6-benzyladenine were detected only in urine samples of colorectal tumor bearing patients. "
3.	Lesch-Nyhan Syndrome (Choreoathetosis Self Mutilation Hyperuricemia Syndrome) 10/01/1998 - "It has been reported that 9-ethyladenine (9-EA) is an efficient inhibitor of APRT (adenine phosphoribosyltransferase) and that its administration causes self-injurious behavior (Lesch-Nyhan Syndrome-like symptoms) in HPRT (hypoxanthine-guanine phosphoribosyltransferase)-deficient mice. "

1.	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)
2.	Bromine
3.	Adenine Phosphoribosyltransferase
4.	benzylaminopurine